Invention Grant
- Patent Title: Dosage forms comprising a plasma kallikrein inhibitor
-
Application No.: US16767803Application Date: 2018-11-28
-
Publication No.: US11234939B2Publication Date: 2022-02-01
- Inventor: John Herman Collett , Gary Paul Cook , Jamie Joseph Farrar , Michael John Frodsham , Michael Bryan Roe , Richard Simon Todd , Robert Neil Ward
- Applicant: KALVISTA PHARMACEUTICALS LIMITED
- Applicant Address: GB Wiltshire
- Assignee: KALVISTA PHARMACEUTICALS LIMITED
- Current Assignee: KALVISTA PHARMACEUTICALS LIMITED
- Current Assignee Address: GB Wiltshire
- Agency: BakerHostetler
- Priority: GB1721515 20171221
- International Application: PCT/GB2018/053443 WO 20181128
- International Announcement: WO2019/106361 WO 20190606
- Main IPC: A61K9/48
- IPC: A61K9/48 ; A61K9/16 ; A61K9/20 ; A61K9/28 ; C07D401/14 ; A61K9/00 ; A61K45/06
Abstract:
The present invention relates to oral solid dosage forms comprising a plasma kallikrein inhibitor, in particular a solid form (Form 1) of the compound of Formula A. Also provided are methods of preparing oral solid dosage forms comprising the compound of Formula A using Form 1 of the compound of Formula A.
Public/Granted literature
- US20200345647A1 DOSAGE FORMS COMPRISING A PLASMA KALLIKREIN INHIBITOR Public/Granted day:2020-11-05
Information query
